NexTel Medical Corp. Forms JV To Commercialize Exosome Hair Regeneration Tech

NexTel Medical Corp. executed a definitive joint venture to commercialize a patented, exosome-delivered hair regeneration formula, with launch targeted for Q4 2026.Material DetailsContext by AI AnalystThis is an early-stage strategy move by a clinical-stage company to enter a large consumer-therape…